"It is the purpose of p-medicine to deliver an architecture that will allow to drive medicine to more individualized treatments based on exploiting the vast amount of heterogeneous data of single patients by software, services, tools and models that will support physicians in decision making in their daily care of patients," said p-medicine project coordinator Prof. Dr. Norbert Graf, Director of the Department of Pediatric Oncology and Hematology, Saarland University (Germany).
"All presented use-case scenarios have been actively discussed and only the mutually agreed versions have been considered," added Prof. Graf, who helped elaborate the first project deliverables while contributing and coordinating the input from all project partners.
"Project partners demonstrated a strong commitment and an active enrolment. The p-medicine project is an interdisciplinary and collaborative research activity. One of the learnt lessons is: we are in the right direction with high skilled and experienced partners," concluded Prof. Graf.
In p-medicine 19 partners from 9 European countries and Japan have dedicated themselves to enable support and sustain new knowledge and innovative technologies to overcome current problems in clinical research and pave the way for a more individualized treatment of cancer. p-medicine unifies European experts in different fields (clinicians, biologists, IT-specialists, ethical and legal experts) to develop and exploit data and tools that support translational research in every aspect.
For further information, please visit:
http://www.p-medicine.eu
Related article:
- FP7 Projects: p-medicine
About p-medicine project
The European Integrated Project p-medicine is supported by the European Commission under the 7th Framework Programme, Grant agreement number 270089.
